NCT00935350View on ClinicalTrials.gov

Reduction of the Glycemic Index by a Novel Viscous Polysaccharide

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

June 30, 2006

Study Completion Date

August 31, 2006

Conditions
Blood Glucose, Postprandial
Interventions
DIETARY_SUPPLEMENT

PolyGlycopleX (PGX)

2.5 grams of PGX

DIETARY_SUPPLEMENT

PolyGlycopleX (PGX)

5.0 grams of PGX

DIETARY_SUPPLEMENT

PolyGlycopleX (PGX)

0 grams of PGX

Trial Locations (1)

Unknown

Glycemic Index Laboratories, Inc., Toronto

Sponsors
All Listed Sponsors
collaborator

InovoBiologic Inc.

INDUSTRY

collaborator

Canadian Center for Functional Medicine

OTHER

lead

Glycemic Index Laboratories, Inc

INDUSTRY

NCT00935350 - Reduction of the Glycemic Index by a Novel Viscous Polysaccharide | Biotech Hunter | Biotech Hunter